Assessing the role of ADAM10 in Trastuzumab treatment and resistance by Feldinger, K

Mechanisms and effects of the heterogeneous response of CAIX to hypoxia by Feldinger, K

Profile of neratinib and its potential in the treatment of breast cancer by Feldinger K, Kong A

Get full text

THE ROLE OF ADAM17 IN HER2 MODERATELY EXPRESSING BREAST CANCER by Feldinger, K, Kerry, J, Gijsen, M, Murphy, G, Kong, A

Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models by Arshad, M, Azad, A, Chan, PYK, Vigneswara, V, Feldinger, K, Nafi, SNM, Laporte-Maguire, E, De Santo, C, Zuo, J, Shaaban, AM, Kong, A

Adaptation to HIF1α deletion in hypoxic cancer cells by upregulation of GLUT14 and creatine metabolism by Valli, A, Morotti, M, Zois, CE, Albers, PK, Soga, T, Feldinger, K, Fischer, R, Frejno, M, McIntyre, A, Bridges, E, Haider, S, Buffa, FM, Baban, D, Rodriguez, M, Yanes, O, Whittington, HJ, Lake, HA, Zervou, S, Lygate, CA, Kessler, BM, Harris, AL